Genetics of Human Fat Cells Used to Predict Response to Anti-Diabetes Drugs

A new study from Penn Medicine shows that a person’s individual genetic variation may affect which medications are best to take. Drugs called …

Sky-rocketing Insulin Prices Prompt New Movement Across the U.S.

More than 7 million Americans are insulin dependent. And recent findings show that 1-in-4 Americans are rationing their insulin, a dangerous way …

One in Four Patients Skimp on Insulin Because of High Cost, Study

One-quarter of patients with type 1 or type 2 diabetes have reported using less insulin than prescribed due to high costs, a new Yale University …

New Drug Maybe in Sight to Treat Diabetes-Related Blindness

Australian scientists have developed a novel drug which could potentially be used to effectively treat patients with diabetic retinopathy; the main …

Teva Recalls Blood Pressure Medication in the U.S.; Adds to Growing List

Teva Pharmaceutical Industries announced this week it is voluntarily recalling some of its blood pressure drugs in the U.S. due to an impurity in …

FDA Issues Voluntary Recall of Blood Pressure Medication Due to Cancer Concerns

A voluntary recall of a blood pressure medication due to impurities, which may lead to a cancer risk, was recently issued by Sandoz Inc. The company …

Security Guidelines for Air Travel With Diabetes

The holidays are coming, and that means it’s travel time for many to spend time with friends and family. If you have diabetes, you should be …

Lilly’s Trulicity® Shows Reduction of Cardiovascular Events for Broad Range of People with Type 2 Diabetes

Eli Lilly and Company reported that it’s drug, Trulicity® significantly reduced major adverse cardiovascular events, a composite endpoint of …

Endocrine Society Urges More Transparency to Combat Soaring Insulin Costs

Out-of-control insulin costs have created a dangerous barrier for many people with diabetes who need to access lifesaving treatments. According to …

Xeris Pharma Announces FDA to Review NDA for Its Ready-to-Use Glucagon Rescue Pen

Xeris Pharmaceuticals, Inc. announced today that its new drug application (NDA) for its ready-to-use, room-temperature stable liquid glucagon rescue …